MeSH tree: E05.318.372.250
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, and few show cardiovascular benefits at one year, according to an analysis of the latest evidence ...
5 hours ago
0
0
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a new study by Weill Cornell ...
Jul 7, 2026
0
10
At least 500 people have died out of over 1,500 confirmed cases in Congo's Ebola outbreak, authorities said, as frontline workers threatened to go on strike on Monday over unpaid benefits and poor working conditions.
Jul 6, 2026
0
2
A pioneering food additive that can stop people from gaining weight has appeared on the EU's Novel Food List, indicating its safety for human consumers. Inulin propionate ester, or IPE, is a dietary fiber developed and tested ...
Jul 2, 2026
0
62
A major international study published in JAMA Network Open has identified practical actions that could improve the quality, usefulness and reliability of randomized clinical trials around the world. The research, conducted ...
Jul 1, 2026
0
2
Alzheimer's disease is a progressive and permanent loss of nerve cells in the brain. The breakdown causes memory loss, functional impairment and personality changes. In a new study published in Nature Aging, researchers found ...
Jun 25, 2026
0
14
Known by acronyms that need no explanation, viruses like COVID, SARS and Ebola conjure images of medics in protective suits and spark fear in populations worldwide.
Jun 25, 2026
0
11
The U.S. Food and Drug Administration has approved GSK's Utebzi (tebipenem pivoxil), an oral antibiotic, for the treatment of complicated urinary tract infections (cUTIs).
Jun 23, 2026
0
5
The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma ...
Jun 19, 2026
0
8
The U.S. Food and Drug Administration has approved Hepcludex (bulevirtide‐gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis or compensated cirrhosis. Approval of Hepcludex ...
Jun 5, 2026
0
5
